newsfilter
← Latest News
GlobeNewswire·

Galectin Therapeutics to Present at the H.C. Wainwright 9th Annual MASH Investor Conference

NORCROSS, Ga., Oct. 20, 2025 (GLOBE NEWSWIRE) -- Galectin Therapeutics, Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins, today announced that the company management will